






































The “Mitochondrial Theory of Aging” posits that a 
decline in mitochondrial function over time is an 
underlying cause of aging [1, 2]. There are many 
observations consistent with this theory, including that 
mitochondria of young animals are relatively small and 
bioenergetically efficient but over time they become 
less numerous, swollen, and chronically depolarized  
[3]. 
 
Increasing evidence implicates a multi-protein complex 
called the mitochondrial permeability transition pore 
(mPTP) in the decline in mitochondrial dysfunction 
with age. Within young cells, mitochondria are 
impermeable to most ions and solutes, allowing them to 
maintain membrane potential and store Ca2+ [4].  As age  
 
 




































advances, however, small disturbances to cellular 
homeostasis increasingly trigger mPTP formation.  Well 
known triggers include increased levels of ROS and 
increased Ca2+ [5].  Acute triggering of the mPTP can 
lead to apoptosis whereas low-level, chronic triggering 
results in mitochondrial swelling, membrane de-
polarization, and the destruction of defective 
mitochondria by autophagy [6]. After three decades of 
research, the mechanisms that underlie increased 
mitochondrial membrane permeability with age remains 
poorly understood. 
 
The structure of the mPTP includes the voltage-
dependent ion channel (VDAC), adenine nucleotide 
translocator (ANT), and cyclophilin D (CypD). Binding 



















Abstract:  Cardiac  failure  is  a  leading  cause  of  age‐related  death,  though  its  root  cause  remains  unknown.  Mounting
evidence  implicates  a  decline  in  mitochondrial  function  due  to  increased  opening  of  the  mitochondrial  permeability
transition  pore  (mPTP).  Here  we  report  that  the  NAD+‐dependent  deacetylase  SIRT3  deacetylates  the  regulatory
component of the mPTP, cyclophilin D (CypD) on lysine 166, adjacent to the binding site of cyclosporine A, a CypD inhibitor.
Cardiac myocytes  from mice  lacking SIRT3 exhibit an age‐dependent  increase  in mitochondrial swelling due to  increased
mPTP opening, a phenotype that is rescued by cyclosporine A.  SIRT3 knockout mice show accelerated signs of aging in the
heart including cardiac hypertrophy and fibrosis at 13 months of age.  SIRT3 knockout mice are also hypersensitive to heart
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connects the mitochondrial matrix with the cytosol [7].  
The therapeutic value of maintaining the mPTP in a 
closed state is highlighted by the resistance of CypD 
knockout mice (Ppif-/-) to a variety of diseases, 
including autoimmune encephalomyelitis (EAE), 
sarcoglycan deficiency, laminin deficiency, collagen VI 
deficiency, ALS (SODG93A), cardiac ischemia–
reperfusion injury, and Alzheimer’s disease (AD) [8, 9].  
These findings have made CypD a drug target of high 
interest [10, 11]. Unfortunately, pharmacological 
inhibitors of CypD, such as cyclosporine A (CsA), also 
inhibit the structurally-related cyclophilins CypA and 
CypB, which are critical for immune function [12].  
Thus, understanding how the mPTP is regulated could 
identify ways to specifically inhibit the mPTP without 
compromising immunity. 
 
The mammalian sirtuins are a family of seven protein 
deacetylases that are increasingly thought to underlie 
many of the health benefits of calorie restriction [13]. 
What makes sirtuins distinct from other deacetylases is 
their requirement for NAD+ as a co-substrate [14]. 
There are three mitochondrial sirtuins, SIRT3, SIRT4 
and SIRT5, which are known to regulate fatty acid 
oxidation, respiration, amino acid metabolism, and the 
urea cycle [15, 16]. Known substrate targets include 
acetyl coenzyme A synthetase 2 (ACS2) [17, 18], 



























acyl coenzyme A dehydrogenase (LCAD) [20]. SIRT3 
can also act as a tumor suppressor by lowering levels of 
ROS and possibly by altering cellular metabolism [21].  
 
We recently reported that cell survival in response to 
genotoxic stress is governed by the levels of 
mitochondrial NAD+ (mNAD+) [22], not on the levels 
of cytoplasmic NAD+, as previously thought. Using cell 
culture, we also identified the mitochondrial sirtuin 
SIRT3 as a downstream mediator of this cell survival 
pathway. In this study, we explore the physiological 
relevance of this process in a major post-mitotic tissue, 
the heart, and identify the acetylation of lysine 166 on 
CypD as a critical target of SIRT3 that dictates the pace 




SIRT3 delays opening of the mPTP in aged cardiac 
muscle 
 
Based on our previous work, we hypothesized that 
SIRT3 might increase cell survival by regulating a 
mitochondrial protein that dictates cell viability. We 
focused on the heart, a post-mitotic tissue where 
mitochondria are critical for sustained function, making 
it an ideal organ system for evaluating mitochondrial 



























Figure  1.  SIRT3  prevents  mitochondrial  permeability  transition  in  cardiac  tissue  during  aging.
Mitochondrial swelling induced by Ca2+. Mitochondria from 3 (A), 6 (B) and 16 months old (C) wt and SIRT3‐/‐ mouse
hearts  subjected  to  Ca2+‐induced  mitochondrial  swelling,  measured  as  %  decrease  in  the  initial  optical  density
(OD540) in the presence or absence of 1 µM CsA (n=4 per group and age). All error bars show s.e.m.  
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To assess the role of SIRT3 in mitochondrial function 
and cell survival in the heart, mitochondria were 
isolated from hearts of both wild-type and SIRT3-/- mice 
at various ages and tested for alterations in the 
susceptibility of mitochondria to opening of the mPTP, 
a well-known characteristic of aged tissues [23].  We 
utilized the Ca2+-overload swelling assay, a sensitive 
assay for mPTP opening.  At 3 and 6 months of age, 
there was no difference between the wild-type and 
SIRT3-/- samples (Figure 1A, B) but by 16 months of 
age, the mitochondria isolated from the hearts of the 
SIRT3-/- mice were significantly more prone to Ca2+-
induced mitochondrial swelling (Figure 1C).  This 
sensitivity was completely rescued by the mPTP 
inhibitor CsA, demonstrating that the defect in the aged 
SIRT3-/- tissues was likely caused by increased mPTP 
opening. Thus, SIRT3 suppresses the increase in mPTP 
formation in the heart during aging. 
 
CypD is acetylated on K166  
 
To identify potential interactors that might provide 

































aging, we performed immunoprecipitation experiments 
with SIRT3 and subjected the precipitated material for 
identification by mass spectrometry.  The predominant 
interactors with SIRT3 were two components of the 
mPTP, namely ANT and VDAC.  Extensive analysis of 
these proteins, however, failed to identify an acetylated 
lysine that was a direct target of SIRT3 (data not 
shown). Although we did not detect CypD as an 
interactor in these immunoprecipitation experiments, 
our observation that CsA reversed the SIRT3-/- 
mitochondrial phenotype (see Figure 1C), strongly 
indicated that CypD was directly involved. 
 
To test this possibility, we first immunoprecipitated 
CypD and identified lysine 166 (K166) as a site of 
acetylation (Figure 2A, B). Interestingly this site is 
highly conserved from yeast to human (Figure 2C). 
During the course of this study, acetylation of K166 
was also described [24] but incorrectly reported as 
K145 because the authors did not include the 
mitochondrial targeting sequence. In fact, cyclophilin 
D (Gene ID: 105675) does not possess a lysine at 


































obtained  from mass  spectrometry  analyses  of  Flag‐purified mouse  Cyclophilin D.  (B)  Sequence  of  Cyclophilin D  (Mus
musculus).  Location  of  the  identified  acetylation  site.  (Peptide:  blue;  acetylated  Lysine:  red).  (C)  Protein  sequence
alignment of CypD from Saccharomyces cerevisiae, Danio rerio, Mus musculus, Homo sapiens. Lysine 166 is marked in red.
  




































SIRT3 interacts and deacetylates CypD in vitro and 
in vivo 
 
Interestingly, by analysis of the CypD structure [25], we 
found that CypD-K166 lies adjacent to the CsA binding 
pocket of CypD (Figure 3A), suggesting that acetylation 
of K166 on CypD might regulate the mPTP.  By co-
immunoprecipitation, SIRT3, but not the other mito-
chondrial sirtuins SIRT4 or SIRT5, interacted with 
CypD (Figure 3B). To monitor the acetylation status of 
CypD in cell culture, we generated a polyclonal 
antibody against the acetylated form of K166 (Ac-
K166) using an acetylated peptide (Figure 3C). This 
antibody did not recognize the mutant CypD-K166R, 
thus demonstrating its specificity. Coexpression of 
CypD and SIRT3 resulted in deacetylation of CypD-
K166 but not when a catalytic mutant of SIRT3 
(H248Y) was expressed (Figure 3C). To test whether 
SIRT3 can directly deacetylate CypD, we purified both 




































and incubated them with purified CypD in the presence 
of NAD+.  Wild-type SIRT3 but not a catalytically 
inactive SIRT3 mutant (SIRT3-H248Y) deacetylated 
SIRT3, demonstrating that SIRT3 can directly 
deacetylate CypD-K166 (Figure 3D). 
 
SIRT3 knockout mice are hypersensitive to heart 
stress 
 
Numerous genetic studies implicate formation of the 
mPTP in the sensitivity of cardiac tissue to stresses 
including ischemia-reperfusion injury, increased 
pressure load, and cardiac changes during aging [10, 
26].  For example, mice lacking cyclophilin D show 
reduced infarct size after coronary artery ligation and 
reperfusion and are relatively resistant to cardiac 
fibrosis and left ventricle enlargement [26].  
 
To test whether the interaction between SIRT3 and CypD 
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subjected SIRT3-/- mice to cardiac stress induced  by 
transaortic constriction (TAC), a procedure that increases 
cardiac afterload and promotes cardiac hypertrophy. Wild 
type and SIRT3-/- male littermates at 3 months of age (n = 
8 and 11 respectively) were subjected to a TAC proce-

















































mice died in the first 20 days following the TAC 
procedure, whereas none of the wild-type mice died 
(Figure 4A). In the SIRT3-/- mice that survived, there was 
a high incidence of cardiac hypertrophy, based on the 
size of the hearts  (Figure 4B) and the size of the left 





















































/‐  (n=11). p < 0.05.  (B) Representative  image and Masson’s  trichrome  staining of hearts  from wt and SIRT3‐/‐ mice 4
weeks after the TAC surgery . Heart weight tibia  length ratio of wt and SIRT3‐/‐ mice 30 days after the TAC surgery wt
(n=8), SIRT3‐/‐ (n=4) mice. (C) Interventricular septal thickness at diastole (Ivs;d) of 2 and 13 month old wt and SIRT3‐/‐ 
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SIRT3 delays age-related changes in the heart 
 
To test the function of SIRT3 in the aging heart, we 
examined the hearts of SIRT3-/- mice at multiple time 
points during their lifespan. Two of the hallmarks of the 
aging heart are cardiac hypertrophy and fibrosis. We 
observed an age-dependent increase in left ventricular 
thickness in SIRT3-/- mice from ages 2 to 13 months, 
which was comparable to the hypertrophy we observed 
in the 3-month-old wild-type mice after transverse 
aortic constriction (TAC).  We also observed a greater 
age-dependent increase in both the left ventricular 
thickness (Figure 4C) and the formation of cardiac 
fibrosis (Figure 4D) in hearts from SIRT3-/- mice 
compared to the wild-type controls between ages 3 to 
13 months, demonstrating that SIRT3 delays age-related 






































mitochondrial function in heart tissue during induced 
stress and during aging. Our data show that SIRT3 
controls the mPTP and that a loss of SIRT3 activity leads 
to increased activation of the mPTP in response to Ca2+ 
increases, cardiac stress, and during aging, all resulting in 
a decline in cardiac function. In this study we focused on 
the heart, an energy-demanding post-mitotic tissue but 
we do not rule out the possibility that speculate that this 
process may affect other energy-demanding organs, a 
possibility we are currently testing. 
 
Mitochondrial NAD+ levels [22] and SIRT3 levels [20, 
27] are both known to increase in response to exercise, 
fasting, and dietary restriction [28].  The ability of 
SIRT3 to suppress excessive mPTP formation may 
explain some of health benefits of diet and exercise on 
cardiac function in middle-aged and elderly people [29]. 
Conversely, a decline in mNAD+ levels during aging or 
in response to obesity, leading to lower SIRT3 activity, 
could explain the decline in heart function during aging 



































Figure  5.  Regulation  of  the mPTP  by  SIRT3.  In  normal  cardiac  tissue,  SIRT3  targets  CypD,
maintaining  it  in  a  deacetylated  state,  thus  preventing  opening  of  the  mPTP  during  aging  and
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During the course of this study, Sundaresan et al. [30] 
reported that young SIRT3-/- mice are hypersensitive to 
agonist-mediated cardiac hypertrophy, which is in 
agreement with our findings by inducing hypertrophy 
by the TAC procedure. Their hypothesis to explain the 
phenotype was that SIRT3 suppresses ROS by 
activating FOXO-mediated transcription of a 
manganese superoxide dismutase and catalase. Our 
results shed light on a more direct and upstream cause 
of the knockout phenotype that may synergize with a 
decline in antioxidant defenses. We propose that 
increased sensitivity to mPTP formation in the absence 
of SIRT3 promotes mitochondrial leakage, which, in 
turn, promotes increased ROS production and a 
reduction in the ability of cells to cope with it. This 
positive feedback cycle likely damages mitochondria 
and results in even greater increase of the acetylation 
state of CypD over time, ultimately leading to 
mitochondrial dysfunction and destruction.  
 
SIRT3 can also control cell survival by promoting the 
sequestration of the pro-apoptotic protein Bax to Ku70 
within the cytoplasm [31]. Another study showed that 
SIRT3 stimulates the detachment of hexokinase II from 
the outer mitochondrial membrane by deacetylating 
CypD, a step necessary for stimulating oxidative 
phosphorylation  [24]. Together, these findings indicate 
that by regulating the mPTP, as our data shows, SIRT3 
ensures that metabolic and cell survival signals within 
the mitochondrial matrix are coordinated with those 
occurring in the cytoplasm. 
 
We propose the following model to explain an age-
dependent decline in cardiac function. An initial 
reduction in SIRT3 activity, perhaps resulting from 
mitochondrial DNA damage, leads to increases in the 
susceptibility of mPTP formation. This then reduces 
the ability of mitochondria to generate NAD+ [32], 
leading to a positive feedback cycle that accelerates 
mitochondrial depolarization and destruction (Figure 
5).  
 
Cyclosporin A is a drug used in transplant operations to 
suppress organ rejection. Its potent suppressive effect 
on immune function precludes its use to treat chronic 
diseases, including cardiac hypertrophy and heart 
failure. This work indicates that a potentially fruitful 
approach would be to activate SIRT3 directly using 
small molecules. Small molecules that directly activate 
SIRT1 have been reported [33, 34], but none yet for 
SIRT3.  It is our hope that this work further stimulates 
research aimed at finding SIRT3 activators. Such 
molecules may allow us to delay aging and effectively 
treat a wide range of age-related diseases. 
METHODS  
 
Mouse strains and genotyping. Studies used wild-type 
and SIRT3-/- 129Sv as described [19]. All animal studies 
were performed according to IACUC-approved 
protocols. Mice were genotyped by standard PCR 
methods as described [19]. 
 
Antibodies and histology. Antibodies used were specific 
for SIRT3 (Cell Signaling and [22]), CypD 
(Mitosciences), Flag (Sigma), HA epitope (Sigma). A 
rabbit polyclonal antibody was raised against a peptide 
of CypD, KTDWLDG-AcK-HVVFGH (YenZym 
Antibodies). Heart sections were stained using Masson 
Trichrome (IMEB, San Marcos, California).  
 
Western blotting. Samples were separated on Tris-HCl 
4 - 20% Criterion (BioRad) gels and transferred to 
nitrocellulose membrane (BioRad). Immunoblots were 
developed with enhanced chemiluminescence 
(Denville). 
 
Plasmid construction and mutagenesis. All expression 
constructs were generated by using PCR-based standard 
cloning strategies, and all expression constructs were 
verified by DNA sequencing. The mouse CypD coding 
sequence was PCR-amplified from mouse full-length 
Mammalian Gene Collection cDNA obtained through 
Open Biosystems (www.openbiosystems.com) and 
cloned into the pcDNA3.1+ (Invitrogen)-derived 
vectors pcDNAFlag to yield CypD with a C-terminal 
Flag. Site-directed mutagenesis for CypD constructs 
was performed with QuikChange site-directed 
mutagenesis kit (Stratagene, La Jolla, CA) as 
recommended by the manufacturer. pcDNA-hSIRT3-
Flag and pcDNA-hSIRT3H248Y-Flag constructs were 
described previously  [19]. 
 
CypD structure and modeling. The crystal structure of 
human CypD in complex with its inhibitor Cyclosporin 
A (PDB ID: 2Z6W) [25]  was used as a template and 
the location of K166 was analyzed by using a 3D-
Software (Cn3D). 
 
Acetylation Analysis by LC-MS/MS. Excised gel bands 
were cut into approximately 1 mm3 pieces.  The 
samples were reduced with 1 mM DTT for 30 minutes 
at 60ºC and then alkylated with 5 mM iodoacetamide 
for 15 min in the dark at room temperature.  Gel pieces 
were then subjected to a modified in-gel trypsin 
digestion procedure.  Gel pieces were washed and 
dehydrated with acetonitrile for 10 min followed by 
removal of acetonitrile.  Pieces were then completely 
dried in a speed-vac.  Rehydration of the gel pieces was 
with 50 mM ammonium bicarbonate solution containing 
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12.5 ng/µl modified sequencing-grade trypsin 
(Promega, Madison, WI) at 4ºC.   Samples were then 
placed in a 37ºC room overnight.  Peptides were later 
extracted by removing the ammonium bicarbonate 
solution, followed by one wash with a solution 
containing 50% acetonitrile and 5% acetic acid.  The 
extracts were then dried in a speed-vac (~1 hr).  The 
samples were then stored at 4ºC until analysis.  On the 
day of analysis the samples were reconstituted in 5 µl of 
HPLC solvent A (2.5% acetonitrile, 0.1% formic acid).  
A nano-scale reverse-phase HPLC capillary column was 
created by packing 5 µm C18 spherical silica beads into 
a fused silica capillary (100 µm inner diameter x 12 cm 
length) with a flame-drawn tip.  After equilibrating the 
column each sample was pressure-loaded off-line onto 
the column.  The column was then reattached to the 
HPLC system.  A gradient was formed and peptides 
were eluted with increasing concentrations of solvent B 
(97.5% acetonitrile, 0.1% formic acid).   
 
As each peptide was eluted they were subjected to 
electrospray ionization and then they entered into an 
LTQ-Orbitrap mass spectrometer (ThermoFinnigan, 
San Jose, CA).  Eluting peptides were detected, isolated, 
and fragmented to produce a tandem mass spectrum of 
specific fragment ions for each peptide.  Peptide 
sequences (and hence protein identity) were determined 
by matching protein or translated nucleotide databases 
with the acquired fragmentation pattern by the software 
program, Sequest (ThermoFinnigan, San Jose, CA). The 
modification of 42.0106 mass units to lysine was 
included in the database searches to determine 
acetylated peptides.  Each acetylated peptide that was 
determined by the Sequest program was also manually 
inspected to ensure confidence [35, 36]. 
 
Transverse Aortic Constriction (TAC) surgery. Mice 
were anesthetized with isofluorane (1-2% in oxygen, 
dose to effect) IH. Mice were intubated using a 22GA 
Angiocath and put on a small animal ventilator CWE. 
Ventilation parameters were: Tidal volume 0.25ml, 
Resp. rate 110 br/min, Insp. Time 0.3 sec. The operative 
field was shaved, cleaned with 10% Betadine and 70% 
ETOH. A median sternotomy was performed with 
hemostasis achieved using the Gemini microcautery 
system. The ascending aorta was dissected from the 
surrounding connective tissue and a absorbable 6-0 PDS 
II coated suture by Ethicon without needle was placed 
around the transverse aorta. The suture was tied down 
against a blunted 27G needle and the needle was 
removed to create a chronic model of hypertrophy/heart 
failure.  The chest cavity was closed by continuous 
absorbable 6-0 PDS II coated suture by Ethicon and 9 
mm wound clips for the skin. The animal was put on a 
warm pad for faster recovery.  The mouse was then 
disconnected from the ventilator and extubated as soon 
as good spontaneous respirations have resumed. 
Dehydration was prevented by administration of 1-2 
ml/100g body wt. of warm 0.9% saline subcutaneously 
at the end of the procedure. The surgical procedure was 
followed by administration of an analgesic 
(Buprenorphine 0.05 mg/kg subcutaneously (2x a day 
for first 48h post operatively, minimum 4 doses). A 
medical record documented the following information 
at least once a day for at least 48 hours after the 
procedure: general status, appetite, pain level and 
quality of incision. Cardiac hypertrophy in mice 
subjected to TAC was assessed by Mouse 
echocardiography. 
 
Mouse echocardiography. Mice were anesthetized under 
isoflurane vaporizer (VetEquip) and the paws were 
secured to the ECG leads on Vevo Mouse Handling 
Table (VisualSonics Inc.).  Body temperature were 
maintained at 37ºC with heating.  Chest hair was 
removed with Nair cream and ultrasound transmission 
gel was applied.  Echocardiography was conducted 
using a Vevo 770 High-Resolution In Vivo Micro-
Imaging System and RMV 707B scanhead 
(VisualSonics Inc.) with heart rate of 500-550 bpm.  M-
mode imaging was obtained with parasternal short axis 
view.  Three consecutive cardiac cycles will be 
measured and averaged according to the 
Recommendations for a Standard Report for Adult 
Transthoracic Echocardiography of the American 
Society of Echocardiography. After the last 
echocardiography assessment the mice was euthanized 
by CO2 asphyxiation, followed by cervical dyslocation. 
Histopathological and proteomic analysis of the hearts 
of euthanized mice will be performed to determine heart 
to tibia length ratios. All animals were monitored daily 
for visual signs of tumors, dehydration, distress or other 
signs of illnesses.  
 
Cell culture and transfections. 293T cells were 
maintained in DMEM supplemented with 10% fetal 
bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 
and 100 µg/ml streptomycin. Cells were transfected 
using Fugene 6 (Roche) and mitochondria were isolated 
48 hr after transfection. 
 
Isolation of mitochondria. Mitochondria from mouse 
hearts were isolated as previously described with slight 
modifications [37, 38]. Hearts were homogenized in 
isolation buffer (250 mM Sucrose, 1 mM EGTA, 5 mM 
HEPES, pH 7.3) containing 1mg of subtilisin A (Sigma) 
per g of tissue and centrifuged at 2500 rpm for 5 min at 
4ºC. The pellet was discarded and the supernatant was 
centrifuged again at 10000 rpm 10 min. The pellet was 
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resuspended in isolation buffer and centrifuged again at 
10000 rpm for 10 min. This step was repeated once 
more and the final pellet was resuspended in isolation 
buffer without EGTA.  Protein concentration was 
determined using a Bradford protein assay (BioRad). 
 
Mitochondrial swelling sssays. Calcium-triggered mito-
chondrial swelling assays were performed as previously 
described [37]. Briefly, 1 mg/ml mg of heart 
mitochondria were suspended in MPTP buffer (200mM 
Sucrose, 10 mM HEPES, 5 mM KH2PO4, 10 µM 
EGTA, pH 7.3) supplemented with 10 mM succinate 
and 1.5 mM rotenone. The mitochondrial swelling was 
triggered by the addition of 600 µM of CaCl2 to heart 
mitochondria in the presence or absence of 1 µM 
Cyclosporin A. Mitochondrial swelling was monitored 
by the decrease in light-scattering at 540 nm in a Cary 
50 MPR spectrophotometer (Varian) for 12 minutes 
[39]. 
 
Immunoprecipitation. Mitochondria were lysed by 
sonication and resuspended in a low-stringency IP 
buffer (0.05% NP-40, 50 mM NaCl, 0.5 mM EDTA, 50 
mM Tris-HCl, pH 7.4, 10 mM nicotinamide, 1 µM 
trichostatin A, protease Inhibitor cocktail (Roche)). 
CypD (Mitosciences) Antibody was used for 
Immunoprecipitation of endogenous CypD. FLAG-
tagged proteins were immunoprecipitated with anti-
FLAG M2-agarose affinity gel (Sigma).  
Immunoprecipitated material was washed four times for 
15 min each in low stringency lysis buffer, and immune 
complexes were resuspended in SDS-PAGE buffer. 
 
In vitro deacetylation assays. Immunoprecipitated 
material was washed in sirtuin deacetylase buffer 
(SDAC) (50 mM Tris-HCl (pH 9.0), 4 mM MgCl2, 50 
mM NaCl, 0.5 mM DTT) buffer. Reactions were 
incubated for 3 h at 32°C with constant agitation after 
addition of NAD+ (1 mM).  
 
Statistical analyses. Results are given as the mean ± 
s.e.m. Statistical analyses represent a non-parametric 
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